These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 5002026

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [The treatment of hemoblastoses and malignant lymphomas. Neoplasms of the lymphoreticular tissue, plasmacytoma and Waldenström's disease. (II)].
    Löffler H, Schultis K.
    Med Welt; 1968 Feb 10; 6():393-6. PubMed ID: 4977038
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Therapy of hemoblastoses. V. Plasmocytoma and macroglobulinemic reticulosis of Walderström].
    Danieli G.
    G Clin Med; 1967 Feb 10; 48(2):164-74. PubMed ID: 4971622
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Results and current biological bases of therapy of malignant hemoreticulopathies].
    Berceanu S, Gociu M, Geib R, Sighetea E, Dăncescu I, Segal E, Tănăsescu C.
    Stud Cercet Med Interna; 1971 Feb 10; 12(3):211-28. PubMed ID: 5002655
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Appropriateness of applying the response criteria for multiple myeloma to Waldenstrom's macroglobulinemia?
    Bladé J, Montoto S, Rosiñol L, Montserrat E.
    Semin Oncol; 2003 Apr 10; 30(2):329-31. PubMed ID: 12720163
    [Abstract] [Full Text] [Related]

  • 11. The International Prognostic Scoring System for Waldenstrom's macroglobulinemia is applicable in patients treated with rituximab-based regimens.
    Dimopoulos MA, Kastritis E, Delimpassi S, Zomas A, Kyrtsonis MC, Zervas K.
    Haematologica; 2008 Sep 10; 93(9):1420-2. PubMed ID: 18641029
    [No Abstract] [Full Text] [Related]

  • 12. Fludarabine in Waldenstrom's macroglobulinemia.
    Leblond V, Choquet S.
    Semin Oncol; 2003 Apr 10; 30(2):239-42. PubMed ID: 12720144
    [Abstract] [Full Text] [Related]

  • 13. [Therapy of paraproteinemic hemoblastoses].
    Fereberger W.
    Acta Med Austriaca; 1982 Apr 10; 9(4):151-7. PubMed ID: 6814158
    [Abstract] [Full Text] [Related]

  • 14. Rituximab-based treatments in Waldenström's macroglobulinemia.
    Dimopoulos MA, Kastritis E, Roussou M, Eleutherakis-Papaiakovou E, Migkou M, Gavriatopoulou M, Tassidou A, Terpos E.
    Clin Lymphoma Myeloma; 2009 Mar 10; 9(1):59-61. PubMed ID: 19362975
    [Abstract] [Full Text] [Related]

  • 15. [Therapy of Waldenstrom's disease and of heavy chain disease].
    Schubert JC.
    Hamatol Bluttransfus; 1976 Mar 10; 18():401-17. PubMed ID: 823079
    [No Abstract] [Full Text] [Related]

  • 16. [Waldenström's hyperglobulinemic purpura, Waldenström's macroglobulinemia].
    Fischer M.
    Thromb Diath Haemorrh Suppl; 1968 Mar 10; 30():155-6. PubMed ID: 5005718
    [No Abstract] [Full Text] [Related]

  • 17. [Current treatment of Kahler's disease and Waldenström's macroglobulinemia].
    Seligmann M, Meshaka G.
    Sem Ther; 1965 Mar 10; 41(6):373-5. PubMed ID: 4964847
    [No Abstract] [Full Text] [Related]

  • 18. IgM heavy chain fragments in Waldenström's macroglobulinemia.
    Bhoopalam N, Lee BM, Yakulis VJ, Heller P.
    Arch Intern Med; 1971 Sep 10; 128(3):437-40. PubMed ID: 4999186
    [No Abstract] [Full Text] [Related]

  • 19. Value of serum viscosity measurements in assessing the response to therapy in myeloma and Waldenström's macroglobulinaemia.
    Kok DA.
    Bibl Anat; 1967 Sep 10; 9():252-8. PubMed ID: 4961775
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.